Detection of the G17V RHOA Mutation in Angioimmunoblastic T-Cell Lymphoma and Related Lymphomas Using Quantitative Allele-Specific PCR

• Rie Nakamoto-Matsubara,

  Affiliation Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan

  ⨯
• Mamiko Sakata-Yanagimoto,

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Terukazu Enami,

  Affiliation Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan

  ⨯
• Kenichi Yoshida,

  Affiliation Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan

  ⨯
• Shintaro Yanagimoto,

  Affiliation Division for Health Service Promotion, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Yusuke Shiozawa,

  Affiliation Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan

  ⨯
• Tohru Nanmoku,

  Affiliation Department of Clinical Laboratory, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Kaishi Satomi,

  Affiliation Department of Pathology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Hideharu Muto,

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Naoshi Obara,

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Takayasu Kato,

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan, Life Science Center, Tsukuba Advanced Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan

  ⨯
• Naoki Kurita,

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Yasuhisa Yokoyama,

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Koji Izutsu,

  Affiliations Department of Hematology, Toranomon Hospital, Minato-ku, Tokyo, Japan, Okinaka Memorial Institute for Medical Research, Minato-ku, Tokyo, Japan

  ⨯
• Yasunori Ota,

  Affiliation Department of Pathology, Toranomon Hospital, Minato-ku, Tokyo, Japan

  ⨯
• Masashi Sanada,

  Affiliation Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan

  ⨯
• Seiichi Shimizu,

  Affiliations Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan, Department of Hematology, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan

  ⨯
• Takuya Komeno,

  Affiliations Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan, Department of Hematology, Mito Medical Center, National Hospital Organization, Ibaraki-machi, Ibaraki, Japan

  ⨯
• Yuji Sato,

  Affiliation Department of Hematology, Tsukuba Memorial Hospital, Tsukuba, Ibaraki, Japan

  ⨯
• Takayoshi Ito,

  Affiliation Department of Hematology, JA Toride Medical Center, Toride, Ibaraki, Japan

  ⨯
• Issay Kitabayashi,

  Affiliation Division of Hematological Malignancy, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan

  ⨯
• Kengo Takeuchi,

  Affiliation Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan

  ⨯
• Naoya Nakamura,

  Affiliation Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Seishi Ogawa,

  Affiliation Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan

  ⨯
•  [ ... ],
• Shigeru Chiba

  * E-mail: schiba-tky@umin.net

  Affiliations Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan, Life Science Center, Tsukuba Advanced Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan

  ⨯
• [ view all ]
• [ view less ]